REVENUE MEMORANDUM CIRCULAR NO. 36-2020 issued on April 6, 2020 further clarifies the exemption from Documentary Stamp Tax (DST) of relief for qualified loans pursuant to Revenue Regulations No. 8-2020 and Revenue Memorandum Circular No.

REVENUE MEMORANDUM CIRCULAR NO. 35-2020 issued on April 2, 2020 exempts from Documentary Stamp Tax (DST) the relief for loans granted under Revenue Regulations (RR) No. 8-2020. All banks, quasi-banks, financing companies, lending companies and

REVENUE MEMORANDUM CIRCULAR NO. 34-2020 issued on March 30, 2020 suspends the running of the Statute of Limitations in the assessment and collection of taxes pursuant to Section 223 of the National Internal Revenue Code

REVENUE MEMORANDUM CIRCULAR NO. 33-2020 issued on March 24, 2020 extends the deadline for availment of Tax Amnesty on Delinquencies from April 23, 2020 to May 23, 2020 due to the declaration of COVID-19 global

REVENUE MEMORANDUM CIRCULAR NO. 5-2022 issued on January 17, 2022 publishes the letter from Director General Rolando Enrique D. Domingo of the Food and Drug Administration endorsing the copy of the “Corrigendum to the List

REVENUE AMINISTRATIVE ORDER NO. 3-2010 issued on September 26, 2010 renames RDO No. 15 – Ilagan, Isabela to RDO No. 15 – Naguilian, Isabela consistent with its new station town or location of office at

REVENUE MEMORANDUM CIRCULAR NO. 4-2022 issued on January 14, 2022 clarifies specific provisions in Revenue Memorandum Order No. 23-2021 relative to guidelines and procedures on Digital/Online Learning in the BIR. Sections VI.5 (c)(viii) and VI.8(a),

REVENUE MEMORANDUM CIRCULAR NO. 3-2022 issued on January 14, 2022 clarifies the preparation of assessment notices for compromise penalty(ies) pursuant to the provisions under Revenue Memorandum Order (RMO) No. 7-2015 and Revenue Regulations (RR) No.